Literature DB >> 10362814

Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.

E Rodríguez-Iñigo1, J Bartolomé, S de Lucas, F Manzarbeitia, M Pardo, C Arocena, J Gosálvez, H Oliva, V Carreño.   

Abstract

It has not been completely elucidated whether the liver injury induced by the hepatitis C virus (HCV) is due to direct cytopathic damage or to an immune-mediated response against HCV-infected hepatocytes. In this work, we have determined the percentage of HCV-infected hepatocytes, the histological activity index, and the viremia levels in chronically HCV-infected patients with different grades of liver injury to investigate any possible correlation between them. For that purpose, liver biopsies from 27 patients with HCV chronic hepatitis were analyzed by in situ hybridization. This technique revealed that the percentage of infected hepatocytes ranged from 0.04% to 83.6%. Regarding the viremia levels, HCV RNA concentration ranged from 1.8 x 10(3) to 1.4 x 10(6) genome copies/ml. A significant correlation (r = 0.54; P = 0.003) between the percentage of infected hepatocytes and the viremia levels was found. In contrast, no correlation was observed between the percentage of HCV-infected hepatocytes or the viremia levels and the histological activity index. In conclusion, we have shown that the HCV viremia reflects the extent of the infection in the liver and that the liver injury in chronic HCV infection is not directly related to either the number of infected hepatocytes or the serum HCV RNA concentration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362814      PMCID: PMC1866612          DOI: 10.1016/S0002-9440(10)65445-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C.

Authors:  E Coelho-Little; L J Jeffers; M Bartholomew; K R Reddy; E R Schiff; P J Dailey
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

2.  HCV viraemia and liver injury in symptom-free blood donors.

Authors:  N Yuki; N Hayashi; T Kamada
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

3.  Changes in hepatitis C virus antigen in liver with antiviral therapy.

Authors:  A M Di Bisceglie; J H Hoofnagle; K Krawczynski
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

4.  Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization.

Authors:  J Moldvay; P Deny; S Pol; C Brechot; E Lamas
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

5.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  J Y Lau; G L Davis; J Kniffen; K P Qian; M S Urdea; C S Chan; M Mizokami; P D Neuwald; J C Wilber
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

6.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

7.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

8.  Hepatitis C virus replication during acute infection in the chimpanzee.

Authors:  M Shindo; A M Di Bisceglie; R Biswas; K Mihalik; S M Feinstone
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

9.  Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease.

Authors:  H Hagiwara; N Hayashi; E Mita; M Naito; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1993-04       Impact factor: 17.425

10.  Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region.

Authors:  K Q Hu; C H Yu; J M Vierling
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

View more
  11 in total

1.  Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

Authors:  L Martin Lagging; Clementina E Garcia; Johan Westin; Rune Wejstål; Gunnar Norkrans; Amar P Dhillon; Magnus Lindh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Intracellular cytokine analysis of CD4-positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C.

Authors:  K Ishii; N Takamura; E Shinohara; H Y Shin; T Ikehara; S Hata; T Kawafune; Y Sumino; Y Ohmoto
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

3.  Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.

Authors:  Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Javier Bartolomé; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

4.  Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C.

Authors:  Javier Bartolomé; Juan Manuel López-Alcorocho; Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Antonio Quiroga; Ricardo Palacios; Vicente Carreño
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

5.  Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

Authors:  Sarah L Fishman; Jacinta M Murray; Francis J Eng; José L Walewski; Susan Morgello; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

6.  A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease.

Authors:  Harel Dahari; Jennifer E Layden-Almer; Eric Kallwitz; Ruy M Ribeiro; Scott J Cotler; Thomas J Layden; Alan S Perelson
Journal:  Gastroenterology       Date:  2009-01-01       Impact factor: 22.682

7.  Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.

Authors:  Sampa Pal; Margaret C Shuhart; Lisa Thomassen; Scott S Emerson; Tao Su; Nathan Feuerborn; John Kae; David R Gretch
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Transglutaminase type II plays a protective role in hepatic injury.

Authors:  Roberta Nardacci; Oreste Lo Iacono; Fabiola Ciccosanti; Laura Falasca; Maria Addesso; Alessandra Amendola; Giorgio Antonucci; Antonio Craxì; Gian Maria Fimia; Valentina Iadevaia; Gerry Melino; Luigi Ruco; Guido Tocci; Giuseppe Ippolito; Mauro Piacentini
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

9.  Chronic hepatitis C.

Authors:  Jae Young Jang; Raymond T Chung
Journal:  Gut Liver       Date:  2011-06-24       Impact factor: 4.519

10.  Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.

Authors:  S K Williams; E Donaldson; T Van der Kleij; L Dixon; M Fisher; J Tibble; Y Gilleece; P Klenerman; A H Banham; M Howard; D P Webster
Journal:  J Viral Hepat       Date:  2013-08-15       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.